Certest Pharma

🙌🏻Certest Pharma had the pleasure of attending the The World Vaccine Congress in Barcelona, represented by our Business Development Specialists: Jiajie Xiang, Andrés Manuel González Ramírez, and Laura de Miguel Acha. Thank you to Terrapinn for organizing such an amazing event, and to everyone who took the time to connect with us. We’re already looking forward to seeing you all again next year in Washington DC! At Certest Pharma, we’re proud to be part of the scientific and biotech community driving forward vaccine development, with a strong focus on mRNA vaccines. 📥If you didn’t get a chance to meet us, feel free to reach out at 𝗯𝗱𝗽𝗵𝗮𝗿𝗺𝗮@𝗰𝗲𝗿𝘁𝗲𝘀𝘁.𝗲𝘀 #WorldVaccineCongress #mRNA #Biotech #CertestPharma

🌍 We're excited to share that our Business Development Manager, Juan Jesús Aznar Morales, represented Certest Pharma at the #PODD Conference in Boston! A big thank you to the organizers and to everyone who had the chance to connect with Jesús during the event. It's amazing to see Drug Delivery take a central role in advancing therapies for conditions from oncology to genetic diseases. If you missed the chance to connect with him, feel free to reach out to us at 𝗯𝗱𝗽𝗵𝗮𝗿𝗺𝗮@𝗰𝗲𝗿𝘁𝗲𝘀𝘁.𝗲𝘀 or 𝗽𝗵𝗮𝗿𝗺𝗮@𝗰𝗲𝗿𝘁𝗲𝘀𝘁.𝗲𝘀 #DrugDelivery #Therapeutics #PharmaInnovation #PODD2024 #CertestPharma  

🌍 Certest Pharma has arrived at the EurAsc Symposium 2024 in Lisbon! Our LNP Formulation Manager, Diego de Miguel, is there over the next two days and will also be presenting tomorrow, October 30th, at 9:50 AM in the Gran Hall. Don’t miss his talk on “𝘐𝘯𝘵𝘦𝘨𝘳𝘢𝘭 𝘓𝘕𝘗 𝘋𝘦𝘭𝘪𝘷𝘦𝘳𝘺 𝘗𝘭𝘢𝘵𝘧𝘰𝘳𝘮 𝘧𝘰𝘳 𝘙𝘕𝘈 𝘛𝘩𝘦𝘳𝘢𝑝𝘦𝘶𝘵𝘪𝘤𝘴 𝘉𝘢𝘴𝘦𝘥 𝘰𝘯 𝘕𝘰𝘷𝘦𝘭 𝘐𝘰𝘯𝘪𝘻𝘢𝘣𝘭𝘦 𝘓𝘪𝑝𝘪𝘥𝘴 𝘸𝘪𝘵𝘩 𝘌𝘯𝘩𝘢𝘯𝘤𝘦𝘥 𝘉𝘪𝘰𝘢𝘤𝘵𝘪𝘷𝘪𝘵𝘺.” Come by our Booth S1 and explore our proprietary technology in ionizable lipids, LNPs, and advanced organ-targeting strategies. 👋🏻See you there! #CertestPharma #EurAscSymposium2024 EurASc European Academy of Sciences  

🌍 𝗖𝗲𝗿𝘁𝗲𝘀𝘁 𝗣𝗵𝗮𝗿𝗺𝗮 𝗶𝘀 𝗮𝘁𝘁𝗲𝗻𝗱𝗶𝗻𝗴 #𝗕𝗜𝗢𝗘𝗨𝗥𝗢𝗣𝗘 𝗳𝗿𝗼𝗺 Biotechnology Innovation Organization! Our team—Juan Jesús Aznar Morales, Business Development Manager; Andrés Manuel González Ramírez and Laura de Miguel Acha, Business Development Specialists—will be attending 𝗕𝗜𝗢𝗘𝗨𝗥𝗢𝗣𝗘 in Stockholm, Sweden from 𝗡𝗼𝘃𝗲𝗺𝗯𝗲𝗿 𝟰-𝟲. #BIOEUROPE presents a fantastic opportunity to connect with industry professionals in the #pharma and biotech sectors. Are you interested in learning more about our proprietary ionizable lipid technology, LNPs, and targeted drug delivery? Don’t hesitate to reach out and schedule a meeting with us. We would be delighted to explore potential synergies! Looking forward to seeing you there! #CertestPharma

𝗧𝗵𝗮𝗻𝗸 𝘆𝗼𝘂, W𝗼𝗿𝗹𝗱 𝗢𝗿𝗽𝗵𝗮𝗻 𝗗𝗿𝘂𝗴 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 𝗕𝗮𝗿𝗰𝗲𝗹𝗼𝗻𝗮! ✨ It was our first time attending this event, and we couldn’t be more grateful for the incredible connections we've made. 🤝 The energy and dedication in the field of rare diseases are truly inspiring! We were particularly excited to explore the advancements in 𝗥𝗡𝗔-𝗯𝗮𝘀𝗲𝗱 𝘁𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 for rare diseases. These innovations offer new hope and potential for patients who need it most. 💉 At Certest Pharma, we remain committed to fighting Orphan Drug challenges and Rare Diseases—together, we can make a difference! 📥If you missed the chance to connect with our colleagues Laura de Miguel Acha and Andrés Manuel González Ramírez, feel free to reach out to us at: bdpharma@certest.es #WorldOrphanDrug #RareDiseases #RNATherapies

🤝🏻 𝗖𝗲𝗿𝘁𝗲𝘀𝘁 𝗣𝗵𝗮𝗿𝗺𝗮 𝗶𝘀 𝗛𝗲𝗮𝗱𝗶𝗻𝗴 𝘁𝗼 𝘁𝗵𝗲 𝗘𝘂𝗿𝗔𝘀𝗰 𝗦𝘆𝗺𝗽𝗼𝘀𝗶𝘂𝗺 𝟮𝟬𝟮𝟰! We are excited to announce our participation in the EurASc European Academy of Sciences 𝗦𝘆𝗺𝗽𝗼𝘀𝗶𝘂𝗺 𝗶𝗻 𝗟𝗶𝘀𝗯𝗼𝗻 𝗼𝗻 𝗢𝗰𝘁𝗼𝗯𝗲𝗿 𝟮𝟵-𝟯𝟬𝘁𝗵⁣ ⁣ 📣We’re particularly proud that our colleague Diego de Miguel, Formulation Department Manager, will have the honor of being a speaker at the event. He will present his talk titled “𝗜𝗻𝘁𝗲𝗴𝗿𝗮𝗹 𝗟𝗡𝗣 𝗗𝗲𝗹𝗶𝘃𝗲𝗿𝘆 𝗣𝗹𝗮𝘁𝗳𝗼𝗿𝗺 𝗳𝗼𝗿 𝗥𝗡𝗔 𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀 𝗕𝗮𝘀𝗲𝗱 𝗼𝗻 𝗡𝗼𝘃𝗲𝗹 𝗜𝗼𝗻𝗶𝘇𝗮𝗯𝗹𝗲 𝗟𝗶𝗽𝗶𝗱𝘀 𝘄𝗶𝘁𝗵 𝗘𝗻𝗵𝗮𝗻𝗰𝗲𝗱 𝗕𝗶𝗼𝗮𝗰𝘁𝗶𝘃𝗶𝘁𝘆” 𝗼𝗻 𝗢𝗰𝘁𝗼𝗯𝗲𝗿 𝟯𝟬 𝗮𝘁 𝟵:𝟱𝟬 𝗔𝗠 𝗶𝗻 𝘁𝗵𝗲 𝗚𝗿𝗮𝗻 𝗛𝗮𝗹𝗹.⁣ ⁣ We invite you to attend his talk and stop by our booth and connect with us to discuss our innovative 𝘁𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝗶𝗲𝘀 𝗳𝗼𝗿 𝘁𝗵𝗲𝗿𝗺𝗼𝘀𝘁𝗮𝗯𝗹𝗲 𝗟𝗡𝗣 𝗮𝗻𝗱 𝗶𝗼𝗻𝗶𝘇𝗮𝗯𝗹𝗲 𝗹𝗶𝗽𝗶𝗱𝘀.⁣ ⁣ Let’s explore how we can collaborate to advance RNA therapeutics together! #CertestPharma #EurAscSymposium2024 #LNPs #IonizableLipids #RNAtherapeutics #Innovation #Networking #Pharma  

🚀 𝗖𝗲𝗿𝘁𝗲𝘀𝘁 𝗣𝗵𝗮𝗿𝗺𝗮 𝗶𝘀 𝗔𝘁𝘁𝗲𝗻𝗱𝗶𝗻𝗴 𝗧𝘄𝗼 𝗞𝗲𝘆 𝗣𝗵𝗮𝗿𝗺𝗮 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀𝗲𝘀! We are excited to announce that members of our 𝗕𝘂𝘀𝗶𝗻𝗲𝘀𝘀 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 𝗧𝗲𝗮𝗺 will be attending two major industry events at the end of October: 1️⃣#PODD: Partnerships in Drug Delivery 📍 Boston, USA 🗓️ October 28-29, 2024 Represented by: Juan Jesús Aznar Morales 2️⃣ The World Vaccine Congress 📍 Barcelona, Spain 🗓️ October 29-31, 2024 Represented by: Andrés Manuel González Ramírez Laura de Miguel Acha, and Jiajie Xiang Our team is looking forward to connecting with industry experts, exploring the latest advancements in drug delivery and therapeutic vaccines, and discussing how 𝗖𝗲𝗿𝘁𝗲𝘀𝘁 𝗣𝗵𝗮𝗿𝗺𝗮 can support your development projects. Don’t miss the opportunity to meet with us at these insightful events! Let’s connect and continue pushing the boundaries of innovation together. #CertestPharma #PODD #WorldVaccineCongress #DrugDelivery #TherapeuticVaccines

🎗️W𝗼𝗿𝗹𝗱 𝗕𝗿𝗲𝗮𝘀𝘁 𝗖𝗮𝗻𝗰𝗲𝗿 𝗗𝗮𝘆: 𝗦𝘂𝗽𝗽𝗼𝗿𝘁𝗶𝗻𝗴 𝘁𝗵𝗲 𝗙𝗶𝗴𝗵𝘁 𝗧𝗵𝗿𝗼𝘂𝗴𝗵 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 ⁣ At Certest Pharma, we stand for the World Breast Cancer Day and those who are affected and committed to supporting the fight from a scientific perspective. In recent years, groundbreaking 𝗥𝗡𝗔-𝗯𝗮𝘀𝗲𝗱 𝘁𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 have opened new possibilities in the treatment of #breastcancer, offering hope and innovative solutions for patients. We are proud to be part of a field that is pushing the boundaries of science to develop more targeted and effective treatments. 💊Together, through innovation and research, we can make strides in the fight against breast cancer. #CertestPharma #WorldBreastCancerDay #BreastCancerAwareness  

𝗥𝗡𝗔 𝗰𝗼𝗻𝘁𝗶𝗻𝘂𝗲𝘀 𝘁𝗼 𝗯𝗲 𝗮 𝗸𝗲𝘆 𝗽𝗹𝗮𝘆𝗲𝗿 𝗶𝗻 𝘁𝗵𝗲 𝗳𝗶𝗲𝗹𝗱 𝗼𝗳 𝗺𝗲𝗱𝗶𝗰𝗮𝗹 𝘀𝗰𝗶𝗲𝗻𝗰𝗲, 𝗮𝘀 𝗵𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝗲𝗱 𝗯𝘆 𝘁𝗵𝗲 𝟮𝟬𝟮𝟰 𝗡𝗼𝗯𝗲𝗹 𝗣𝗿𝗶𝘇𝗲 𝗶𝗻 𝗣𝗵𝘆𝘀𝗶𝗼𝗹𝗼𝗴𝘆 𝗼𝗿 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗲 𝗮𝘄𝗮𝗿𝗱𝗲𝗱 𝗳𝗼𝗿 𝘁𝗵𝗲 𝗱𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 𝗼𝗳 𝗺𝗶𝗰𝗿𝗼𝗥𝗡𝗔! 🧬 Although the award was announced last week, its importance remains ever relevant. After the initial excitement, we at 𝗖𝗲𝗿𝘁𝗲𝘀𝘁 𝗣𝗵𝗮𝗿𝗺𝗮 remain proud of our ongoing contributions to the rapidly growing world of RNA-based therapies, pushing the boundaries of what’s possible in drug delivery and gene regulation. 🚀 The potential of #RNA technologies is only beginning to unfold, and we're excited to be part of this incredible journey. This is just the start—much more innovation is ahead! 🌍 💡Learn more about microRNA at: https://lnkd.in/eBw3mwcV #RNATherapies #Innovation #DrugDelivery #NobelPrize #microRNA #Biotech #CertestPharma

🔬 Today, let’s start the day with our section of #DeliveringScience so let’s Explore the Versatility of Lipid Nanoparticles (LNPs) in Therapeutic Delivery Lipid Nanoparticles (LNPs) have emerged as a powerful tool for the delivery of a wide range of therapeutic molecules, offering precise and efficient encapsulation. But what types of payloads can these advanced systems accommodate? Here are some of the most promising therapeutic cargos that LNPs can carry: • 𝗺𝗥𝗡𝗔: Paving the way for groundbreaking vaccines and therapies. ⁣ • 𝘀𝗮𝗥𝗡𝗔 (𝘀𝗲𝗹𝗳-𝗮𝗺𝗽𝗹𝗶𝗳𝘆𝗶𝗻𝗴 𝗥𝗡𝗔): ⁣ Offering enhanced efficacy with smaller doses. ⁣ • 𝘁𝗥𝗡𝗔: ⁣ Targeting translational processes to regulate protein synthesis. • 𝘀𝗶𝗥𝗡𝗔:⁣ Silencing specific genes for disease treatment. • 𝗗𝗡𝗔: ⁣Gene therapies and vaccines with long-term potential. ⁣ • 𝗣𝗿𝗼𝘁𝗲𝗶𝗻𝘀 𝗮𝗻𝗱 𝗣𝗲𝗽𝘁𝗶𝗱𝗲𝘀: For targeted therapeutic applications. • 𝗦𝗺𝗮𝗹𝗹 𝗠𝗼𝗹𝗲𝗰𝘂𝗹𝗲𝘀: ⁣Enhancing bioavailability and targeted delivery. 💊The versatility of LNPs makes them an essential platform in the development of therapies for a wide range of diseases, from cancer to infectious diseases and beyond. At Certest Pharma, we are continuously innovating in the field of 𝗟𝗡𝗣-𝗯𝗮𝘀𝗲𝗱 𝗱𝗿𝘂𝗴 𝗱𝗲𝗹𝗶𝘃𝗲𝗿𝘆⁣ to help shape the future of therapeutics. #CertestPharma #LNPs #mRNA #saRNA #tRNA #siRNA #DrugDelivery #Biotech #Pharma #TherapeuticInnovation #ScientificResearch